Compare NVAX & CTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVAX | CTBI |
|---|---|---|
| Founded | 1987 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 1996 | 1995 |
| Metric | NVAX | CTBI |
|---|---|---|
| Price | $9.05 | $70.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 1 |
| Target Price | $11.33 | ★ $63.00 |
| AVG Volume (30 Days) | ★ 4.8M | 65.7K |
| Earning Date | 05-06-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 3.26% |
| EPS Growth | ★ 309.76 | 17.79 |
| EPS | N/A | ★ 1.50 |
| Revenue | ★ $1,123,479,000.00 | N/A |
| Revenue This Year | N/A | $14.02 |
| Revenue Next Year | N/A | $4.30 |
| P/E Ratio | ★ N/A | $46.86 |
| Revenue Growth | ★ 64.69 | N/A |
| 52 Week Low | $6.20 | $50.25 |
| 52 Week High | $11.85 | $70.47 |
| Indicator | NVAX | CTBI |
|---|---|---|
| Relative Strength Index (RSI) | 45.45 | 67.93 |
| Support Level | $8.89 | $64.34 |
| Resistance Level | $9.02 | N/A |
| Average True Range (ATR) | 0.68 | 1.45 |
| MACD | -0.21 | 0.35 |
| Stochastic Oscillator | 18.10 | 89.95 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and south-central Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services. The company operates in one reportable segment: community banking services.